Yantai Dongcheng Pharmaceutical Co., Ltd. (002675)
Market Open
11 Aug, 06:57
XSHE XSHE Primary ¥
13. 28
+0.09
+0.6823%
¥
12.34B Market Cap
- P/E Ratio
0.12% Div Yield
1.45M Volume
- Eps
¥ 13.19
Previous Close Want to track 002675 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002675 trading today higher at ¥13.28, an increase of 0.6823% from yesterday's close, completing a monthly increase of 5.9856% or ¥0.75. Over the past 12 months, 002675 stock lost -4.1155%.
002675 pays dividends to its shareholders, with the most recent payment made on Apr 29, 2026. The next estimated payment will be in In 8 months on Apr 29, 2027 for a total of ¥0.08062.
The last earnings report, released on Mar 26, 2026, missed the consensus estimates by -0.16%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Yantai Dongcheng Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Aug 30, 2016.
The company's stock is traded on one exchange.
002675 Chart
People also search for
Yantai Dongcheng Pharmaceutical Co., Ltd. (002675) FAQ
What is the stock price today?
The current price is ¥13.28.
On which exchange is it traded?
Yantai Dongcheng Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002675.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.12%.
What is its market cap?
As of today, the market cap is 12.34B.
Has Yantai Dongcheng Pharmaceutical Co., Ltd. ever had a stock split?
Yantai Dongcheng Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Aug 30, 2016.
Yantai Dongcheng Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Zhi Gang Luo CEO | XSHE Exchange | CNE100001DP5 ISIN |
| CN Country | 2,469 Employees | 29 Apr 2026 Last Dividend | 30 Aug 2016 Last Split | 25 May 2012 IPO Date |
Overview
Yantai Dongcheng Pharmaceutical Group Co., Ltd., a conglomerate in the pharmaceutical industry, with its subsidiaries, delves into the production and distribution of biochemical Active Pharmaceutical Ingredients (APIs), finished dosage forms, nuclide drugs, and health-related products. These offerings cater to several therapeutic domains, including cardiovascular diseases, antitumor, urology, orthopedics, among others. Established in 1998, this enterprise has its roots and headquarters in Yantai, China, and has expanded its market footprint across approximately 40 countries and regions worldwide, covering Europe, the Americas, Asia Pacific, and other international territories.
Products and Services
- APIs and Healthcare Products: The company produces essential biochemical APIs like heparin, chondroitin sulphate sodium and calcium, glucosamine series products, along with other critical healthcare products including collagen, hyaluronic acid, and cytochrome C. These ingredients and products are vital for various health supplements and medications.
- Prescription Medications: Offering a range of prescription drugs, Dongcheng Pharmaceutical provides solutions such as nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection. Additionally, it manufactures ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule for various medical conditions.
- Nuclide Drugs: The firm is a key player in the production of nuclide drugs used in diagnostic imaging and treatment of diseases. Products include Technetium [99Tc] Methylene Diphosphonate Injection and Technetium [99mTc] Tc labeled tracers for imaging, 2-[18F]FDG to detect tumor cell activity, sodium iodide [131I] oral solution and iodine [125I] seed for internal radiation treatment of malignant tumors, and [14C]Urea capsule for specific diagnostic uses.
- Nutritional Supplements: Furthermore, Yantai Dongcheng Pharmaceutical Group provides health supplements like the jiabaolin glucosamine chondroitin sulfate capsule, catering to nutritional needs and overall well-being.
Contact Information
Address: No.7 ChangBaiShan Road, Yantai, China, 264006
Phone: 86 53 5639 1521
Website: https://www.dcb-group.com
